Latest New Zealand News

RMA Global Limited has reported its first cash flow positive quarter since listing, alongside a 9% revenue increase driven by strong US and ANZ market performance and the strategic acquisition of Curated Social.

Change Financial Limited reported a robust Q2 FY25 with revenue surging 53% year-on-year, driven by its expanding PaaS platform, while strategically exiting its loss-making US operations to sharpen focus on Australia and New Zealand.

MedAdvisor Limited reported a significant 38.6% drop in 2Q FY25 revenue due to vaccine program deferrals but expects a stronger second half driven by a diversified US pipeline and cost-saving initiatives.

Alcidion Group Limited reported robust Q2 FY25 sales of $13.1 million and improved cash flow, reinforcing its forecast to achieve EBITDA and cashflow positivity by the end of FY25.

Cyclone Metals has forged a strategic partnership with Vale S.A. to fund and develop its Iron Bear iron ore project in Canada, marking a major step towards mining decision. The company also completed pilot production of high-grade direct reduction pellets, underscoring the project's technical promise.

Acusensus has secured major contract expansions across Australia and New Zealand, driving a 15.8% revenue increase in Q2 FY25 and bolstering its cash reserves to $30.3 million. The company’s strategic international push and innovative enforcement technologies position it for sustained growth.

Cue Energy delivered a robust quarter with $4.3 million net cash flow and a $17.1 million cash balance, driven by strong drilling results and production growth across its Australian and Indonesian assets.

Nuchev Limited has reported its first positive operating cashflow quarter alongside a 65% increase in revenue for the first half of FY25, driven by strong sales growth and the bWellness acquisition.

AVADA Group Limited reports a positive cash flow for Q4 2024, supported by increased collections and operational consolidation, even as government funding shifts delay project starts.

CurveBeam AI Limited reported a remarkable 150% increase in device purchase orders in Q2 FY25, driven by strong demand for its HiRise™M platform and a new commercial agreement with Stryker. The company is advancing validation of its Enhanced HiRise™ for robotic surgical systems, despite a regulatory delay for its BMD SaaS module.

CurveBeam AI has reported a record quarter for HiRise™ device purchase orders, driven by a strategic expansion with Stryker in Australia and New Zealand. The company also advanced its FDA regulatory pathway for its BMD module, setting sights on mid-2025 submission.

Experience Co Limited reports robust Q2 2025 earnings growth, driven by strong revenue gains in skydiving and adventure experiences despite ongoing macroeconomic challenges. The company highlights operational efficiencies and positive cash flow amid a gradual inbound tourism recovery.